Abbott Laboratories shares stall below resistance at $102.46 as momentum splits on MACD and Bull/Bear Power: weekly analysis

Traders Union
All News
Stocks
Abbott Laboratories slips 3.76% this week

Highlights

Shares of Abbott Laboratories declined 3.76% over the past week and now trade at $100.93.
The stock remains below longer-term moving averages and is consolidating near support at $100.82, pointing to a bearish technical structure.
Over the next five sessions, the expected price range is $97.04 to $104.81, with a high probability of further downside.

Spin-off announcement and forecast revision drive mixed sentiment as earnings rise

Abbott reported third-quarter 2026 earnings with sales rising 7% year-over-year and adjusted earnings-per-share up 9%, as highlighted by Yahoo Finance. The company also unveiled plans to spin off its Nutrition business into a separately listed company through a tax-free distribution by the end of 2027 (source: The Motley Fool). The move was accompanied by an updated full-year sales growth forecast to approximately 6% and market concern around the spin-off's potential risks for ABT in the coming week (source: TradingKey).

Mixed momentum signals highlight technical standoff near key support and resistance

On the daily chart, the setup is defined by a sharp move lower without a sustained trend, with volatility over the past week at 8.89%. Momentum signals are mixed: MACD is on a strong sell reading at -0.23, while Bull/Bear Power indicates overbought conditions. The price is sitting on support at $100.82, marked by the Ichimoku Kijun, with resistance up at $102.46 from the 200-day moving average. This technical backdrop signals the move is still developing, and a clearer trend would require follow-through below support or a sustained recovery above resistance.

Downside risk prevails for next week as range and breakout triggers are defined

Over the next five trading days, the expected range is $97.04 to $104.81. There is a very low probability of an increase (less than 20%) and a very high probability of a decrease (more than 80%). Base case sees the stock holding between the $100.82 support and $102.46 resistance. A bullish scenario would require a close above $102.46 to challenge the upper end of the range, while sustained weakness below $100.82 opens the door for a move toward $97.04.

Jainam Mehta, market strategist, sees Abbott Laboratories shares under pressure this week, dropping around 4% and remaining stuck between key support at $100.82 and resistance at $102.46. He notes that the company’s strong third-quarter earnings and the planned spin-off of its Nutrition business add complexity, with news flow contributing to market indecision. Technical signals remain mixed, with MACD negative and volatility elevated, while sentiment is dominated by concerns over potential downside risk. "A clear directional move may require a break of $100.82 support or a close above $102.46—until then, I expect a rangebound week as investors weigh the spin-off news against lingering technical weakness."

Earlier, analysts noted that Abbott Laboratories shares faced downside risks and were likely to remain in a consolidative holding pattern given mixed technical signals. The current setup reinforces this cautious outlook, with the prevailing scenario focused on potential downside risk and a close watch on $100.82 as the primary support level in the days ahead.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.